Cigarette smoke-induced oxidative stress suppresses generation of dendritic cell IL-12 and IL-23 through ERK-dependent pathways

Journal of Immunology

Volumn 181, Issue 2, 2008, Pages 1536-1547

  Kroening, Paula R ^a,b   Barnes, Terrance W ^b   Pease, Larry ^a,b   Limper, Andrew ^a,b   Kita, Hirohito ^a,b   Vassallo, Robert ^a,b  

^a MAYO CLINIC   (United States)

^b Stabile Building 8 54 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; CATALASE; CD40 LIGAND; CIGARETTE SMOKE; INTERLEUKIN 12; INTERLEUKIN 12P70; INTERLEUKIN 23; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE 3; NICOTINE; PROTEIN P35; PROTEIN P40; PROTEIN SUBUNIT; TUMOR NECROSIS FACTOR ALPHA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN C FOS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MATURATION; CELL NUCLEUS; CIRCULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; LUNG; MOUSE; NONHUMAN; ONCOGENE C FOS; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; SMOKING; TRANSCRIPTION INITIATION; ANIMAL; CELL CULTURE; IMMUNOLOGY; METABOLISM;

ANIMALS; ANTIOXIDANTS; CELLS, CULTURED; DENDRITIC CELLS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; INTERLEUKIN-12; INTERLEUKIN-23; MICE; NICOTINE; OXIDATIVE STRESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-FOS; SMOKING;

EID: 49049107795     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.2.1536     Document Type: Article

References (59)

1. Banchereau, J., and A. K. Palucka. 2005. Dendritic cells as therapeutic vaccines against cancer. Nat. Rev. Immunol. 5: 296-306. (Pubitemid 40516155)
2. Cooper, A. M., J. Magram, J. Ferrante, and I. M. Orme. 1997. Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis. J. Exp. Med. 186: 39-45.
3. Langrish, C. L., B. S. McKenzie, N. J. Wilson, R. de Waal Malefyt, R. A. Kastelein, and D. J. Cua. 2004. IL-12 and IL-23: master regulators of innate and adaptive immunity. Immunol. Rev. 202: 96-105.
4. Happel, K. I., E. A. Lockhart, C. M. Mason, E. Porretta, E. Keoshkerian, A. R. Odden, S. Nelson, and A. J. Ramsay. 2005. Pulmonary interleukin-23 gene delivery increases local T-cell immunity and controls growth of Mycobacterium tuberculosis in the lungs. Infect. Immun. 73: 5782-5788.
5. Happel, K. I., P. J. Dubin, M. Zheng, N. Ghilardi, C. Lockhart, L. J. Quinton, A. R. Odden, J. E. Shellito, G. J. Bagby, S. Nelson, and J. K. Kolls. 2005. Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae. J. Exp. Med. 202: 761-769.
6. Khader, S. A., J. E. Pearl, K. Sakamoto, L. Gilmartin, G. K. Bell, D. M. Jelley-Gibbs, N. Ghilardi, F. deSauvage, and A. M. Cooper. 2005. IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN-γ responses if IL-12p70 is available. J. Immunol. 175: 788-795.
7. Altare, F., A. Durandy, D. Lammas, J. F. Emile, S. Lamhamedi, F. Le Deist, P. Drysdale, E. Jouanguy, R. Doffinger, F. Bernaudin, et al. 1998. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science 280: 1432-1435. (Pubitemid 28264836)
8. Aste-Amezaga, M., X. Ma, A. Sartori, and G. Trinchieri. 1998. Molecular mechanisms of the induction of IL-12 and its inhibition by IL-10. J. Immunol. 160:5936-5944. (Pubitemid 28298054)
9. Broderick, L., S. P. Brooks, H. Takita, A. N. Baer, J. M. Bernstein, and R. B. Bankert. 2006. IL-12 reverses anergy to T cell receptor triggering in human lung tumor-associated memory T cells. Clin. Immunol. 118: 159-169. (Pubitemid 43199654)
10. Oppmann, B., R. Lesley, B. Blom, J. C. Timans, Y. Xu, B. Hunte, F. Vega, N. Yu, J. Wang, K. Singh, et al. 2000. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13: 715-725.
11. Aggarwal, S., N. Ghilardi, M. H. Xie, F. J. de Sauvage, and A. L. Gurney. 2003. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J. Biol. Chem. 278: 1910-1914. (Pubitemid 36801431)
12. Aujla, S. J., Y. R. Chan, M. Zheng, M. Fei, D. J. Askew, D. A. Pociask, T. A. Reinhart, F. McAllister, J. Edeal, K. Gaus, et al. 2008. IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat. Med. 14:275-281. (Pubitemid 351347908)
13. Overwijk, W. W., K. E. de Visser, F. H. Tirion, L. A. de Jong, T. W. Pols, Y. U. van der Velden, J. G. van den Boorn, A. M. Keller, W. A. Buurman, M. R. Theoret, et al. 2006. Immunological and antitumor effects of IL-23 as a cancer vaccine adjuvant. J. Immunol. 176: 5213-5222.
14. den Boon, S., S. W. van Lill, M. W. Borgdorff, S. Verver, E. D. Bateman, C. J. Lombard, D. A. Enarson, and N. Beyers. 2005. Association between smoking and tuberculosis infection: a population survey in a high tuberculosis incidence area. Thorax 60: 555-557.
15. Altet-Gomez, M. N., J. Alcaide, P. Godoy, M. A. Romero, and I. Hernandez del Rey. 2005. Clinical and epidemiological aspects of smoking and tuberculosis: a study of 13,038 cases. Int. J. Tuberc. Lung. Dis. 9: 430-436.
16. Gajalakshmi, V., R. Peto, T. S. Kanaka, and P. Jha. 2003. Smoking and mortality from tuberculosis and other diseases in India: retrospective study of 43000 adult male deaths and 35000 controls. Lancet 362: 507-515. (Pubitemid 36976714)
17. Nuorti, J. P., J. C. Butler, M. M. Farley, L. H. Harrison, A. McGeer, M. S. Kolczak, and R. F. Breiman. 2000. Cigarette smoking and invasive pneumococcal disease: active bacterial core surveillance team. N. Engl. J. Med. 342: 681-689.
18. Kark, J. D., M. Lebiush, and L. Rannon. 1982. Cigarette smoking as a risk factor for epidemic a(h1n1) influenza in young men. N. Engl. J. Med. 307: 1042-1046.
19. Matsunaga, K., T. W. Klein, H. Friedman, and Y. Yamamoto. 2001. Involvement of nicotinic acetylcholine receptors in suppression of antimicrobial activity and cytokine responses of alveolar macrophages to Legionella pneumophila infection by nicotine. J. Immunol. 167: 6518-6524. (Pubitemid 33081587)
20. Nouri-Shirazi, M., and E. Guinet. 2003. Evidence for the immunosuppressive role of nicotine on human dendritic cell functions. Immunology 109: 365-373. (Pubitemid 36783262)
21. Zhang, S., and T. M. Petro. 1996. The effect of nicotine on murine CD4 T cell responses. Int. J. Immunopharmacol. 18: 467-478. (Pubitemid 27019984)
22. Hurt, R. D., L. C. Dale, P. A. Fredrickson, C. C. Caldwell, G. A. Lee, K. P. Offord, G. G. Lauger, Z. Marusic, L. W. Neese, and T. G. Lundberg. 1994. Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up: one-year outcome and percentage of nicotine replacement. J. Am. Med. Assoc. 271: 595-600.
23. Mamata, Y., A. Hakki, Y. Yamamoto, C. Newton, T. W. Klein, S. Pross, and H. Friedman. 2005. Nicotine modulates cytokine production by Chlamydia pneumoniae infected human peripheral blood cells. Int. Immunopharmacol. 5: 749-756. (Pubitemid 40248329)
24. Aicher, A., C. Heeschen, M. Mohaupt, J. P. Cooke, A. M. Zeiher, and S. Dimmeler. 2003. Nicotine strongly activates dendritic cell-mediated adaptive immunity: potential role for progression of atherosclerotic lesions. Circulation 107: 604-611. (Pubitemid 36176812)
25. Vassallo, R., K. Tamada, J. S. Lau, P. R. Kroening, and L. Chen. 2005. Cigarette smoke extract suppresses human dendritic cell function leading to preferential induction of Th-2 priming. J. Immunol. 175: 2684-2691. (Pubitemid 41113884)
26. Witschi, H., I. Espiritu, M. Yu, and N. H. Willits. 1998. The effects of phenylethyl isothiocyanate, N-acetylcysteine and green tea on tobacco smoke-induced lung tumors in strain A/J mice. Carcinogenesis 19: 1789-1794. (Pubitemid 28474643)
27. Witschi, H., D. Uyeminami, D. Moran, and I. Espiritu. 2000. Chemoprevention of tobacco-smoke lung carcinogenesis in mice after cessation of smoke exposure. Carcinogenesis 21: 977-982. (Pubitemid 30265143)
28. Matsue, H., D. Edelbaum, D. Shalhevet, N. Mizumoto, C. Yang, M. E. Mummert, J. Oeda, H. Masayasu, and A. Takashima. 2003. Generation and function of reactive oxygen species in dendritic cells during antigen presentation. J. Immunol. 171: 3010-3018. (Pubitemid 37093524)
29. Yan, F., S. Williams, G. D. Griffin, R. Jagannathan, S. E. Plunkett, K. H. Shafer, and T. Vo-Dinh. 2005. Near-real-time determination of hydrogen peroxide generated from cigarette smoke. J. Environ. Monit. 7: 681-687. (Pubitemid 41039519)
30. -/- mice exhibit Th1 cell polarization and increased susceptibility to experimental autoimmune encephalomyelitis. J. Immunol. 176: 5788-5796.
31. Mathur, R. K., A. Awasthi, P. Wadhone, B. Ramanamurthy, and B. Saha. 2004. Reciprocal CD40 signals through p38 MAPK and ERK-1/2 induce counteracting immune responses. Nat. Med. 10: 540-544.
32. Manthey, C. L., S. W. Wang, S. D. Kinney, and Z. Yao. 1998. SB202190, a selective inhibitor of p38 mitogen-activated protein kinase, is a powerful regulator of LPS-induced mRNAs in monocytes. J. Leukocyte Biol. 64: 409-417.
33. Cho, J. H., S. D. Cho, H. Hu, S. H. Kim, S. K. Lee, Y. S. Lee, and K. S. Kang. 2002. The roles of ERK1/2 and p38 MAP kinases in the preventive mechanisms of mushroom Phellinus linteus against the inhibition of gap junctional intercellular communication by hydrogen peroxide. Carcinogenesis 23: 1163-1169.
34. Tomczak, M. F., M. Gadjeva, Y. Y. Wang, K. Brown, I. Maroulakou, P. N. Tsichlis, S. E. Erdman, J. G. Fox, and B. H. Horwitz. 2006. Defective activation of ERK in macrophages lacking the p50/p105 subunit of NF-κB is responsible for elevated expression of IL-12 p40 observed after challenge with Helicobacter hepaticus. J. Immunol. 176: 1244-1251.
35. Wu, C. H., H. H. Lin, F. P. Yan, and C. J. Wang. 2006. Immunohistochemical detection of apoptotic proteins, p53/Bax and JNK/FasL cascade, in the lung of rats exposed to cigarette smoke. Arch. Toxicol. 80: 328-336.
36. 2 receptor activation. J. Cell. Physiol. 210: 99-110.
37. Ishii, T., T. Matsuse, H. Igarashi, M. Masuda, S. Teramoto, and Y. Ouchi. 2001. Tobacco smoke reduces viability in human lung fibroblasts: protective effect of glutathione S-transferase P1. Am. J. Physiol. 280: L1189-L1195. (Pubitemid 32553257)
38. Fu, A. L., Z. H. Dong, and M. J. Sun. 2006. Protective effect of N-acetyl-Lcysteine on amyloid β-peptide-induced learning and memory deficits in mice. Brain Res. 1109: 201-206. (Pubitemid 44279591)
39. Neal, R., R. H. Matthews, P. Lutz, and N. Ercal. 2003. Antioxidant role of Nacetyl cysteine isomers following high dose irradiation. Free Radical Biol. Med. 34: 689-695. (Pubitemid 36288535)
40. Whitekus, M. J., N. Li, M. Zhang, M. Wang, M. A. Horwitz, S. K. Nelson, L. D. Horwitz, N. Brechun, D. Diaz-Sanchez, and A. E. Nel. 2002. Thiol antioxidants inhibit the adjuvant effects of aerosolized diesel exhaust particles in a murine model for ovalbumin sensitization. J. Immunol. 168: 2560-2567.
41. Matsumoto, M., D. Einhaus, E. S. Gold, and A. Aderem. 2004. Simvastatin augments lipopolysaccharide-induced proinflammatory responses in macrophages by differential regulation of the c-Fos and c-Jun transcription factors. J. Immunol. 172: 7377-7384. (Pubitemid 38747598)
42. Hegazi, R. A., K. N. Rao, A. Mayle, A. R. Sepulveda, L. E. Otterbein, and S. E. Plevy. 2005. Carbon monoxide ameliorates chronic murine colitis through a heme oxygenase 1-dependent pathway. J. Exp. Med. 202: 1703-1713.
43. Lambert, C., J. McCue, M. Portas, Y. Ouyang, J. Li, T. G. Rosano, A. Lazis, and B. M. Freed. 2005. Acrolein in cigarette smoke inhibits T-cell responses. J. Allergy Clin. Immunol. 116: 916-922.
44. Khan, N., S. S. Rahim, C. S. Boddupalli, S. Ghousunnissa, S. Padma, N. Pathak, D. Thiagarajan, S. E. Hasnain, and S. Mukhopadhyay. 2006. Hydrogen peroxide inhibits IL-12 p40 induction in macrophages by inhibiting c-Rel translocation to the nucleus through activation of calmodulin protein. Blood 107: 1513-1520. (Pubitemid 43242389)
45. Muller, T., H. J. Haussmann, and G. Schepers. 1997. Evidence for peroxynitrite as an oxidative stress-inducing compound of aqueous cigarette smoke fractions. Carcinogenesis 18: 295-301. (Pubitemid 28132421)
46. Pryor, W. A. 1997. Cigarette smoke radicals and the role of free radicals in chemical carcinogenicity. Environ. Health Perspect. 105(Suppl. 4): 875-882.
47. Khadaroo, R. G., A. Kapus, K. A. Powers, M. I. Cybulsky, J. C. Marshall, and O. D. Rotstein. 2003. Oxidative stress reprograms lipopolysaccharide signaling via Src kinase-dependent pathway in RAW 264.7 macrophage cell line. J. Biol. Chem. 278: 47834-47841.
48. Shi, M. M., J. J. Godleski, and J. D. Paulauskis. 1996. Regulation of macrophage inflammatory protein-1α mRNA by oxidative stress. J. Biol. Chem. 271: 5878-5883.
49. Kode, A., S. R. Yang, and I. Rahman. 2006. Differential effects of cigarette smoke on oxidative stress and proinflammatory cytokine release in primary human airway epithelial cells and in a variety of transformed alveolar epithelial cells. Respir. Res. 7: 132. (Pubitemid 44734067)
50. Kantengwa, S., L. Jornot, C. Devenoges, and L. P. Nicod. 2003. Superoxide anions induce the maturation of human dendritic cells. Am. J. Respir. Crit. Care Med. 167: 431-437. (Pubitemid 36216428)
51. Chan, R. C., M. Wang, N. Li, Y. Yanagawa, K. Onoe, J. J. Lee, and A. E. Nel. 2006. Pro-oxidative diesel exhaust particle chemicals inhibit LPS-induced dendritic cell responses involved in T-helper differentiation. J. Allergy Clin. Immunol. 118: 455-465.
52. Buttari, B., E. Profumo, V. Mattei, A. Siracusano, E. Ortona, P. Margutti, B. Salvati, M. Sorice, and R. Rigano. 2005. Oxidized β2-glycoprotein I induces human dendritic cell maturation and promotes a T helper type 1 response. Blood 106: 3880-3887. (Pubitemid 41739027)
53. Rutault, K., C. Alderman, B. M. Chain, and D. R. Katz. 1999. Reactive oxygen species activate human peripheral blood dendritic cells. Free Radical Biol. Med. 26: 232-238.
54. Murphy, L. O., S. Smith, R. H. Chen, D. C. Fingar, and J. Blenis. 2002. Molecular interpretation of ERK signal duration by immediate early gene products. Nat. Cell Biol. 4: 556-564.
55. Dillon, S., A. Agrawal, T. Van Dyke, G. Landreth, L. McCauley, A. Koh, C. Maliszewski, S. Akira, and B. Pulendran. 2004. A Toll-like receptor 2 ligand stimulates Th2 responses in vivo, via induction of extracellular signal-regulated kinase mitogen-activated protein kinase and c-Fos in dendritic cells. J. Immunol. 172: 4733-4743. (Pubitemid 38456394)
56. Zheng, Y., P. A. Valdez, D. M. Danilenko, Y. Hu, S. M. Sa, Q. Gong, A. R. Abbas, Z. Modrusan, N. Ghilardi, F. J. de Sauvage, and W. Ouyang. 2008. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat. Med. 14: 282-289. (Pubitemid 351347912)
57. Feng, C. G., D. Jankovic, M. Kullberg, A. Cheever, C. A. Scanga, S. Hieny, P. Caspar, G. S. Yap, and A. Sher. 2005. Maintenance of pulmonary Th1 effector function in chronic tuberculosis requires persistent IL-12 production. J. Immunol. 174: 4185-4192.
58. Watkins, R. E., and A. J. Plant. 2006. Does smoking explain sex differences in the global tuberculosis epidemic? Epidemiol. Infect. 134: 333-339. (Pubitemid 43280243)
59. Bates, M. N., A. Khalakdina, M. Pai, L. Chang, F. Lessa, and K. R. Smith. 2007. Risk of tuberculosis from exposure to tobacco smoke: a systematic review and meta-analysis. Arch. Intern. Med. 167: 335-342. (Pubitemid 46333932)